Understanding Pediatric Patient's Perspective on Neurostimulation (Cefaly®™) for Migraine Treatment: A Focus Group Discussion
DOI:
https://doi.org/10.29173/spectrum283Abstract
Purpose: Migraines are highly prevalent among children and adolescents, leading to significant disability. External trigeminal nerve stimulation (Cefaly®) is an emerging alternative treatment for migraine. These non-invasive wearable devices deliver electrical impulses through the skin to reduce pain transmission. Cefaly® has been government-approved for use in adults but has not been formally studied in pediatric-aged populations. We conducted a focus group with pediatric patients (aged 16-17) and a patient partner (aged 18) diagnosed with chronic migraine to investigate adolescent perspectives on the Cefaly® device. Involving adolescents ahead of a clinical trial is critical for understanding whether the Cefaly® device can be integrated into patients' lives and have a meaningful impact in real-world contexts for pain management.
Methods: Participants partook in a 65-minute virtual semi-structured focus group discussion where they were asked open-ended questions regarding their experiences living with chronic migraine and their impressions of the Cefaly® device and barriers to use.
Results: Participants were keen to try Cefaly® but felt it was best suited for home use due to the device's appearance combined with the length of time required per session. Participants described Cefaly® as most helpful as an adjunct for their existing therapies. The device's portability was regarded as advantageous. Participants especially expressed a favourable perception towards the non-invasive nature of Cefaly® and minimal side effects compared to medications and injection-based treatment options.
Conclusion: Adolescents reported a desire to try Cefaly® for treating their chronic migraines. Clinical studies are needed to validate the efficacy of Cefaly® for pediatric populations.
Downloads
Additional Files
Published
License
Copyright (c) 2024 Julia Anne Craig, Kelsey Wright, Pilar McCann, Taylor Ness; Thilinie Rajapakse (Faculty Member/Supervisor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Spectrum encourages authors to publish their work under a Creative Commons Attribution 4.0 International licence (CC BY 4.0) that allows others to distribute, remix, tweak, and build upon the work, even commercially, as long as they credit the Author(s) for the original creation. Authors may, however, choose to have their work distributed under any of the Creative Commons licenses currently available by specifying their preferred licence in the publication agreement. The applicable Creative Commons license icon will appear on the title page of each published submission. A description of the Creative Commons licences is available here: https://creativecommons.org/licenses/